Skip to main content
INNOVATE Corp. logo

INNOVATE Corp. — Investor Relations & Filings

Ticker · VATE ISIN · US45784J1051 LEI · 549300S6O246JWQQ1K58 US Financial and insurance activities
Filings indexed 1,195 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country US United States of America
Listing US VATE

About INNOVATE Corp.

https://innovatecorp.com/

INNOVATE Corp. is a diversified holding company that acquires and manages a portfolio of assets across three primary sectors: Infrastructure, Life Sciences, and Spectrum. The Infrastructure segment, through its subsidiary DBM Global, is a provider of structural steel and industrial construction services. The Life Sciences portfolio focuses on developing innovative healthcare technologies and includes companies such as Pansend Life Sciences, R2 Technologies, which markets an aesthetic dermatology device, and MediBeacon, which has developed a system for assessing kidney function. The Spectrum segment operates through HC2 Broadcasting, a large group of broadcast television stations.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2026-05-14 English
8-K - INNOVATE Corp. (0001006837) (Filer)
Regulatory Filings
2026-04-06 English
8-K - INNOVATE Corp. (0001006837) (Filer)
Regulatory Filings
2026-03-31 English
8-K - INNOVATE CORP. (0001006837) (Filer)
Regulatory Filings
2026-02-10 English
8-K Filing
Regulatory Filings
2026-02-02 English
8-K
Regulatory Filings
2025-12-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.